The alkylphospholipid, perifosine, radiosensitizes prostate cancer cells both <it>in vitro </it>and <it>in vivo</it>
<p>Abstract</p> <p>Background</p> <p>Perifosine is a membrane-targeted alkylphospholipid developed to inhibit the PI3K/Akt pathway and has been suggested as a favorable candidate for combined use with radiotherapy. In this study, we investigated the effect of the combined treatment of perifosine and...
Na minha lista:
| Principais autores: | , , , , , , , , , , , , , |
|---|---|
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
BMC
2011-04-01
|
| 叢編: | Radiation Oncology |
| 在線閱讀: | http://www.ro-journal.com/content/6/1/39 |
| 標簽: |
沒有標簽, 成為第一個標記此記錄!
|
